- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01493037
PICSO in Patients With STEMI Treated by Primary Percutaneous Coronary Intervention (pRAMSES)
July 15, 2014 updated by: Miracor Medical SA
Pressure Controlled Intermittent Coronary Sinus Occlusion in Patients With ST Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: Safety and Feasibility Study
A prospective multi-center study in which patients with an acute heart attack (in the left anterior descending artery) with ECG changes (ST segment elevation) receive angioplasty followed by stent placement and 90 minutes of PICSO treatment.
This is a proof of concept study designed to document the safety and feasibility of the Pressure Controlled Intermittent Coronary Sinus Occlusion (PICSO) Impulse system.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Amsterdam, Netherlands, 1105 AZ
- Academic Medical Center - University of Amsterdam
-
Breda, Netherlands
- Amphia Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
First time anterior STEMI defined by the following:
- Symptoms of myocardial ischemia > 30 minutes and < 12 hours
- ST-segment elevation > 1mm (> 0.1 mV) in two contiguous precordial leads in the anterior territory on a 12-lead ECG
- Uncomplicated PCI of a LAD culprit lesion (defined as angioplasty followed by stent placement or direct stenting without the occurrence of an adverse event(s) that would preclude further study participation, such as major bleeding, perforation, hypotension, pulmonary edema or instability that in the judgement of the investigator preclude participation in the trial)
Exclusion Criteria:
- Younger than 18 years of age
- Hospitalization with a primary diagnosis of acute myocardial infarction (AMI) previously or has evidence of previous Q-wave infarct
- Left main coronary artery culprit lesion
- Additional stenosis in the LAD for which PCI or CABG is likely to be needed in the next 6 months and which is not treated during the index procedure
- Cardiogenic shock (systolic blood pressure ≤90 mmHg in spite of conservative measures) or pulmonary edema (O2 saturation <90% by pulse oximetry and the presence of rales or crackles)
- Cardiac arrest requiring chest compression or resuscitation
- Anatomical complications limit capacity to place PICSO Impulse device or achieve stable catheter placement or occlude coronary sinus
- Known renal disease (GFR < 30 mL/min/1.73m2) or dialysis
- History of stroke, TIA or reversible ischemic neurological disease within last 6 months
- Left bundle branch block
- Known contra-indication for magnetic resonance imaging (Metallic implant precluding MRI, claustrophobia, obesity precluding MRI, etc.)
- Presence of any lead in the coronary sinus
- Active or treated malignancies in the last 12 months
- Previous coronary artery bypass graft surgery
- Known severe anemia (Hgb < 10 g/dL or < 6.2 mmol/L)
- Known platelet count < 100,000, known coagulopathy or bleeding diathesis, or unwilling to accept transfusions
- Participation in another ongoing clinical study
- Women of child-bearing age
- Non-cardiac comorbidities and life expectancy < 1 year
- Legal incompetence
- A condition that, in the opinion of the Investigator, precludes participation, including compliance with all follow-up procedures
- No dependents neither to the sponsor nor to the investigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: PICSO
PICSO treatment for 90 minutes
|
The PICSO catheter has a balloon which is placed in the coronary sinus via the femoral vein.
The balloon is inflated and deflated at intervals calculated by an algorithm and adjusted according to the patient's own coronary sinus pressure plateau.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Successful delivery of PICSO treatment
Time Frame: 90 minutes
|
Assessment of the feasibiity of PICSO in STEMI patients defined as the successful elivery of the PICSO catheter and the successful administration of PICSO treatment for 90 minutes
|
90 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MRI measurement of infarct size
Time Frame: 4 months
|
Infarct size assessed by cardiac MRI between 2-5 days post primary PCI and again at 120 days follow up
|
4 months
|
Assessment of left ventricular function
Time Frame: 4 months
|
Left ventricular function assessed by echocardiography between 2-5 days after primary PCI and at 120 days
|
4 months
|
Assessment of microvascular perfusion
Time Frame: 4 months
|
Microvascular perfusion assessed by cardiac MRI between 2-5 days after primary PCI and at 120 days
|
4 months
|
Resolution of ST-segment elevation
Time Frame: 24 hours
|
Occurrence of complete resolution of ST-segment elevation 30, 60, 90 and 120 minutes after last contrast injection prior to PICSO placement procedure on 24 hour continuous 12 lead ECG Holter monitor recording
|
24 hours
|
Measurement of ST segment time curve area
Time Frame: 3 hours
|
ST segment time curve area for the first 3 hours on 24 hour continuous 12 lead ECG Holter monitor recording.
|
3 hours
|
Number of adverse events
Time Frame: 6 months
|
Safety endpoints recorded are Major Adverse Cardiac Events (MACE), Major Adverse Cardiac and Cerebrovascular Events (MACCE), net adverse clinical events (MACE and bleeding), Serious and non serious Adverse Device Events ((S)ADE) rates
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jan J Piek, Professor, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (ACTUAL)
March 1, 2014
Study Registration Dates
First Submitted
December 13, 2011
First Submitted That Met QC Criteria
December 14, 2011
First Posted (ESTIMATE)
December 15, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
July 16, 2014
Last Update Submitted That Met QC Criteria
July 15, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CIP 2011-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ST Elevation (STEMI) Myocardial Infarction
-
Stony Brook UniversityHennepin County Medical Center, MinneapolisUnknownAcute Coronary Syndrome | STEMI | NSTEMI - Non-ST Segment Elevation MI | Non ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction | Acute Coronary Artery Thrombosis (Diagnosis) | Non ST Segment Elevation Acute Coronary Syndrome and other conditionsUnited States
-
Assiut UniversityNot yet recruitingST-segment Elevation Myocardial Infarction (STEMI)
-
Assiut UniversityUnknownST-segment Elevation Myocardial Infarction (STEMI)
-
Hellenic Cardiovascular Research SocietyCompletedMyocardial Infarction | ST Segment Elevation Myocardial Infarction (STEMI)Greece
-
University College, LondonCompletedST-segment Elevation Myocardial Infarction (STEMI)Mauritius
-
A.H. TavenierIsalaCompletedSTEMI | STEMI - ST Elevation Myocardial InfarctionNetherlands
-
RenJi HospitalNot yet recruitingST-segment Elevation Myocardial Infarction (STEMI)
-
Peking University Third HospitalNot yet recruitingST-segment Elevation Myocardial Infarction (STEMI)
-
The First Affiliated Hospital with Nanjing Medical...Completed
-
Samsung Medical CenterRainMed Medical; Shanghai Institute of Cardiovascular DiseasesActive, not recruitingST-segment Elevation Myocardial Infarction (STEMI)United States, China
Clinical Trials on PICSO (Pressure-controlled Intermittent Coronary Occlusion
-
University Hospital Inselspital, BerneCompletedIschemia | Coronary Artery Disease | Circulation, Collateral | Coronary Sinus | Collateral Flow IndexSwitzerland
-
Salus UniversityUnknownIntermittent ExotropiaUnited States
-
Mansoura UniversityCompletedMechanical VentilationEgypt